Apyx Medical Corp (APYX) Operating Margin
- Operating margin · 12 months: Value -6.06%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -6.06% | Operating income / revenue. Period ending 2026-06-30. $-3.54M ÷ $58.41M × 100 ≈ -6.06% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -3.54M USD | Operating Income (Loss) |
| Revenue | 58.41M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 21.32M USD | Cost of Goods and Services Sold |
| Research and development | 3.30M USD | Research and Development Expense |
| Selling, general and administration | 16.93M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-3.54M | $58.41M | $21.32M | $3.30M | $16.93M | -6.06% |
| 2026-03-31 | $-4.31M | $55.90M | $20.60M | $3.33M | $15.91M | -7.70% |
| 2025-12-31 | $-6.45M | $52.84M | $19.80M | $3.37M | $15.80M | -12.20% |
| 2025-09-30 | $-9.51M | $47.90M | $17.89M | $3.55M | $16.01M | -19.84% |
| 2025-06-30 | $-12.31M | $46.51M | $17.85M | $3.89M | $16.64M | -26.46% |
| 2025-03-31 | $-15.28M | $47.29M | $18.21M | $4.49M | $17.34M | -32.31% |
| 2024-12-31 | $-18.84M | $48.10M | $18.74M | $5.08M | $18.86M | -39.18% |
| 2024-09-30 | $-21.57M | $48.54M | $19.22M | $4.77M | $20.75M | -44.44% |
| 2024-06-30 | $-22.57M | $49.03M | $18.68M | $5.04M | $21.30M | -46.04% |
| 2024-03-31 | $-18.26M | $50.45M | $18.32M | $4.97M | $21.84M | -36.20% |
| 2023-12-31 | $-17.26M | $52.35M | $18.59M | $4.84M | $22.20M | -32.97% |
| 2023-09-30 | $-17.45M | $50.30M | $17.23M | $4.85M | $21.28M | -34.70% |
| 2023-06-30 | $-18.60M | $47.44M | $16.59M | $4.64M | $21.11M | -39.21% |
| 2023-03-31 | $-23.34M | $44.16M | $15.67M | $4.51M | $20.27M | -52.85% |
| 2022-12-31 | $-23.56M | $44.51M | $15.38M | $4.54M | $20.48M | -52.94% |
| 2022-09-30 | $-19.32M | $48.72M | $15.68M | $4.24M | $20.70M | -39.65% |
| 2022-06-30 | $-17.51M | $51.44M | $16.10M | $4.35M | $20.64M | -34.03% |
| 2022-03-31 | $-15.57M | $52.37M | $16.41M | $4.36M | $20.36M | -29.74% |
| 2021-12-31 | $-14.45M | $48.52M | $14.92M | $4.32M | $18.62M | -29.78% |
| 2021-09-30 | $-14.81M | $43.16M | $14.01M | $4.29M | $15.59M | -34.31% |
| 2021-06-30 | $-15.21M | $38.28M | $12.46M | $4.16M | $13.69M | -39.74% |
| 2021-03-31 | $-17.34M | $31.35M | $10.97M | $4.05M | $11.62M | -55.29% |
| 2020-12-31 | $-20.08M | $27.71M | $10.21M | $3.92M | $11.69M | -72.47% |
| 2020-09-30 | $-23.99M | $24.63M | $9.26M | $4.10M | $12.56M | -97.41% |
| 2020-06-30 | $-24.38M | $25.25M | $9.31M | $4.07M | $13.69M | -96.54% |
| 2020-03-31 | $-22.63M | $27.60M | $9.09M | $3.98M | $14.54M | -81.99% |
| 2019-12-31 | $-20.87M | $28.23M | $9.14M | $3.73M | $13.70M | -73.91% |
| 2019-09-30 | $-20.09M | $25.70M | $9.16M | $3.21M | $13.03M | -78.16% |
| 2019-06-30 | $-17.61M | $21.99M | $7.75M | $2.89M | $11.30M | -80.11% |
| 2019-03-31 | $-16.08M | $19.11M | $6.81M | $2.77M | $10.43M | -84.15% |
| 2018-12-31 | $-13.60M | $16.69M | $5.89M | $2.47M | $9.44M | -81.51% |
| 2018-09-30 | $-3.07M | $43.07M | $20.30M | $2.75M | $11.65M | -7.12% |
| 2018-06-30 | $-3.35M | $42.09M | $20.33M | $2.43M | $11.64M | -7.97% |
| 2018-03-31 | $-4.39M | $40.41M | $19.89M | $2.31M | $11.64M | -10.87% |
| 2017-12-31 | $-5.26M | $38.88M | $19.12M | $2.46M | $11.37M | -13.54% |
| 2017-09-30 | $-5.22M | $37.03M | $18.34M | $2.69M | $10.16M | -14.10% |
| 2017-06-30 | $-4.33M | $37.74M | $18.58M | $2.76M | $9.69M | -11.48% |
| 2017-03-31 | $-3.54M | $37.24M | $18.42M | $2.66M | $8.78M | -9.49% |
| 2016-12-31 | $-3.79M | $36.63M | $18.71M | $2.62M | $8.56M | -10.35% |
| 2016-09-30 | $-4.10M | $35.43M | $18.83M | $2.57M | $8.45M | -11.57% |
| 2016-06-30 | $-5.67M | $33.19M | $18.42M | $2.47M | $8.41M | -17.08% |
| 2016-03-31 | $-6.71M | $31.17M | $17.96M | $2.38M | $8.39M | -21.52% |
| 2015-12-31 | $-6.99M | $29.52M | $16.96M | $2.16M | $8.42M | -23.67% |
| 2015-09-30 | $-7.43M | $28.69M | $17.21M | $1.93M | $8.09M | -25.89% |
| 2015-06-30 | $-7.98M | $27.66M | $17.48M | $1.72M | $8.11M | -28.87% |
| 2015-03-31 | $-8.18M | $27.33M | $18.42M | $1.53M | $7.70M | -29.93% |
| 2014-12-31 | $-5.85M | $27.68M | $18.69M | $1.42M | $6.69M | -21.13% |
| 2014-09-30 | $-4.93M | $26.34M | $17.22M | $1.34M | $6.10M | -18.72% |
| 2014-06-30 | $-3.04M | $25.35M | $15.90M | $1.26M | $4.30M | -11.98% |
| 2014-03-31 | $-2.94M | $24.45M | $14.64M | $1.26M | $4.88M | -12.04% |
| 2013-12-31 | $-3.67M | $23.66M | $14.46M | $1.26M | $4.89M | -15.49% |
| 2013-09-30 | $-2.66M | $24.36M | $14.94M | $1.30M | $4.81M | -10.93% |
| 2013-06-30 | $-1.91M | $25.24M | $15.17M | $1.33M | $4.74M | -7.55% |
| 2013-03-31 | $-15.00K | $26.63M | $15.95M | $1.36M | $4.53M | -0.06% |
| 2012-12-31 | $1.05M | $27.67M | $16.34M | $1.33M | $4.34M | 3.78% |
| 2012-09-30 | $-483.00K | $27.00M | $15.81M | $1.24M | $4.36M | -1.79% |
| 2012-06-30 | $-517.00K | $26.59M | $15.68M | $1.21M | $4.26M | -1.94% |
| 2012-03-31 | $-207.00K | $25.99M | $14.90M | $1.15M | $4.27M | -0.80% |
| 2011-12-31 | $-18.00K | $25.41M | $14.68M | $1.20M | $4.35M | -0.07% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-2.75M | $24.23M | $14.24M | $1.85M | $4.89M | -11.36% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $715.00K | $26.95M | $15.10M | $2.08M | $4.66M | 2.65% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |